Analysts foresee more revenue Coloplast

Tomorrow Coloplast will publish it's past quarters results. For this year Coloplast's revenue will be around 17,93 billion Danish Krone. This is according to the average of the analysts' estimates. This is slightly more than 2018's revenue of 16,45 billion Danish Krone.

Historical revenues and results Coloplast plus estimates 2019

The analysts expect for 2019 a net profit of 4,23 billion Danish Krone. For this year most of the analysts expect a profit per share of 19,95 Danish Krone. The price/earnings-ratio is then 39,8.

For this year the analysts expect a dividend of 16,92 Danish Krone per share. Coloplast's dividend yield thus equals 2,13 percent. The average dividend yield of the pharmaceutical companies equals a low -3 percent.

Based on the current number of outstanding shares Coloplast's market capitalization 154,19 billion Danish Krone. The Coloplast stock was the past 12 months quite unstable. Since last August the stock is even 22 percent higher. This year the stock price moved between 570 and 816 DKK.

Historical stock prices Coloplast

ValueSpectrum.com News Wire & Equity Research: +31 084-0032-842
news@valuespectrum.com

Copyright analist.nl B.V.
All rights reserved. Any redistribution, duplication or archiving prohibited. analist.nl doesn't warrant the accuracy of any News Content provided and shall not be liable for any errors, inaccuracies or for any actions taken in reliance thereon.